On 2025-05-27, NurExone Biologic Inc. (V.NRX) announced earnings per share of -0.03 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of -0.02.
The next expected annoucement date for quarterly earnings is 2025-08-26, with an average estimated earnings per share of -0.03 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-27 | 2025-03-31 | -0.02 | -0.03 |
| 2025-04-09 | 2024-12-31 | -- | -0.03 |
| 2024-11-27 | 2024-09-30 | -0.04 | -0.08 |
| 2024-08-27 | 2024-06-30 | -- | -0.03 |
| 2024-05-29 | 2024-03-31 | -0.03 | -0.02 |
| 2024-04-02 | 2023-12-31 | -- | -0.02 |
| 2023-11-24 | 2023-09-30 | -0.03 | -0.03 |
| 2023-08-28 | 2023-06-30 | -0.03 | -0.02 |
| 2023-05-24 | 2023-03-31 | -- | -0.02 |
| 2023-03-30 | 2022-12-31 | -- | -0.04 |
| 2022-11-24 | 2022-09-30 | -- | -0.04 |
| 2022-08-22 | 2022-06-30 | -- | -0.15 |